DNA methylation of the prestin gene and outer hair cell electromotileresponse of the cochlea in salicylate administration

Background/aim: Activity of the prestin gene may have a role in the pathogenesis of salicylate-induced ototoxicity. We investigated DNA methylation for prestin gene exon 1 in salicylate-injected guinea pigs. Materials and methods: Fifteen guinea pigs (30 ears) underwent audiological evaluation including 1000 Hz probe-tone tympanometry and a distortion product otoacoustic emission (DPOAE) test. The animals were randomly divided into three groups. Groups 2 (8 ears) and 3 (14 ears) were injected with intramuscular saline and sodium salicylate (200 mg/kg), respectively twice daily for 2 weeks. Group 1 (8 ears) received no injection. DPOAE measurements were performed at baseline; after 1, 2, 4, and 8 h (acute effect); and after 1 and 2 weeks (chronic effect). After audiological measurements, the animals were sacrificed for DNA isolation. Results: While a significant decrease (P < 0.01) was found for the acute effect in all frequencies in Group 3 according to baseline measurements, there was no difference in terms of chronic effect. DNA methylation increased during the acute phase of salicylate administration, whereas it returned to initial levels during the chronic phase. Conclusion: Salicylate-induced changes in DPOAE responses may be related to prestin-gene methylation. These results may have important implications for salicylate ototoxicity.

PDF

___

1. Kachar B, Brownell R, Altschuler R, Fex J. Electrokinetic shape changes of cochlear outer hair cells. Nature 1986; 322: 365-368.
2. Ashmore JF, Mammano F. Can you still see the cochlea for the molecules? Curr Opinion Neurobiol 2001; 11: 449-454.
3. Dallos P, Falkler B. Prestin, a new type of motor protein. Nat Rev Mol Cell Biol 2002; 3: 104-111.
4. Zheng J, Shen W, He Dz, Long KB, Madison LD, Dallos P. Prestin is the motor protein of cochlear outer hair cells. Nature 2000; 405: 149-155.
5. Dallos P, Wu X, Cheatham MA, Gao J, Zheng J, Anderson CT, Jia S, Wang X, Cheng WH, Sengupta S et al. Prestin-based outer hair cell motility is necessary for mammalian cochlear amplification. Neuron 2008; 58: 333-339.
6. Liberman MC, Gao J, He DZ, Wu X, Jia S, Zuo J. Prestin is required for electromotility of the outer hair cell and for the cochlear amplifier. Nature 2002; 419: 300-304.
7. Oliver D, He DZ, Klöcker N, Ludwig J, Schulte U, Waldegger S, Ruppersberg JP, Dallos P, Fakler B. Intracellular anions as the voltage sensor of prestin, the outer hair cell motor protein. Science 2001; 292: 2340-2343.
8. Hakizimana P, Fridberger A. Effects of salicylate on soundevoked outer hair cell stereocilia deflection. Pflugers Arch Eur J Physiol 2015; 467: 2021-2029.
9. Tunstall MJ, Gale JE, Ashmore JF. Action of salicylate on membrane capacitance of outer hair cells from the guinea-pig cochlea. J Physiol 1995; 485: 739-752.
10. Alvan G, Berninger E, Gustafsson LL, Karlsson KK, Paintaud G, Wakelkamp M. Concentrationresponse relationship of hearing impairment caused by quinine and salicylate: pharmacological similarities but different molecular mechanisms. Basic & Clinical Pharmacology & Toxicology 2017; 120: 5-13.
11. Guitton MJ, Caston J, Ruel J, Johnson Rm, Pujol R, Puel JL. Salicylate induces tinnitus through activation of cochlear NMDA receptors. J Neurosci 2003; 23: 3944-3952.
12. Chan Y. Tinnitus: etiology, classification, characteristics, and treatment. Discov Med 2009; 8: 133-136.
13. Nicolas PC, Faulconhridge RL, Guitton M, Puel JC, Mondain M, Uziel A. Characteristics of tinnitus and etiology of associated hearing loss: a study of 123 patients. International Tinnitus Journal 2002; 8: 37-44.
14. Zenner HP, Vonthein R, Zenner B, Leuchtweis R, Plontke SK, Torka W, Pogge S, Birbaumer N. Standardized tinnitus-specific individual cognitive-behavioral therapy: a controlled outcome study with 286 tinnitus patients. Hear Res 2013; 298: 117-125.
15. Tonndorf J. Acute cochlear disorders: the combination of hearing loss, recruitment, poor speech discrimination and tinnitus. Ann Otol Rhinol Laryngol 1980, 89: 39-44.
16. Martin WH, Schwegler JW, Scheibelhoffer J, Ronis ML. Salicylate induced changes in cat auditory nerve activity. Laryngoscope 1993; 103: 600-604.
17. Yu N, Zhu ML, Jhonson B, Liu YP, Jones RO, Zhao HB. Prestin up-regulation in chronic salicylate (aspirin) administration: an implication of functional dependence of prestin expression. Cell Mol Life Sci 2008; 65: 2407-2418.
18. Parazzini M, Hall AJ, Lutman ME, Kapadia S. Effect of aspirin on phase gradient of 2F1F2 distortion product otoacoustic emissions. Hear Res 2005; 205: 44-52.
19. Huang ZW, Luo Y, Wu Z, Tao Z, Jones RO, Zhao HB. Paradoxical enhancement of active cochlear mechanics in long-term administration of salicylate. J Neurophysiol 2005; 93: 2053-2061.
20. Brenet F, Moh M, Funk P, Feierstein E, Viale AJ, Socci ND, Scandura JM. DNA methylation of the first exon is tightly linked to transcriptional silencing. PLoS ONE 2011; 6: 1-12.
21. Ramsahoye BH, Biniszkiewicz D, Lyko F, Clark V, Bird AP, Jaenisch R. Non-CpG methylation is prevalent in embryonic stem cells may be mediated by DNA methyltransferase 3a. Proc Natl Acad Sci USA 2000; 97: 5237-5242.
22. Jastreboff PJ, Brennan JF, Coleman JK, Sasaki CT. Phantom auditory sensation in rats: An animal model for tinnitus. Behav Neurosci 1988; 102: 811-822.
23. Jastreboff PJ, Brennan JF. Evaluating the loudness of phantom auditory perception (tinnitus) in rats. Audiology 1994; 33: 202- 217.
24. Cazals Y, Horner KC, Huang ZW. Alterations in average spectrum of cochleoneural activity by long-term salicylate treatment in the guinea pig: a plausible index of tinnitus. J Neurophysiol 1998; 80: 2113-2120.
25. Le CS, Avan P, Gilain L, Romand R. CD1 hearing impaired mice. I: distortion product otoacoustic emission levels, cochlear function and morphology. Hear Res 1998; 120: 3750.
26. Li LC, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002; 18: 1427-1431.
27. Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nature Genetics 2003; 33: 245-254.
28. Evans EF, Borerwe TA. Ototoxic effects of salicylates on the responses of single cochlear nerve fibres and on cochlear potentials. Br J Audiol 1982; 16: 101-108.
29. Jastreboff PJ. Phantom auditory perception (tinnitus): mechanisms of generation and perception. Neurosci Res 1990; 8: 221-254.
30. Eggermont JJ. Tinnitus: neurobiological substrates. Drug Discovery Today 2005; 10: 1283-1290.
31. Jastreboff PJ, Hazell JW. A neurophysiological approach to tinnitus: clinical implications. Br J Audiol 1993; 27: 7-17.
32. Eggermont JJ, Roberts LE. Tinnitus: animal models and findings in humans. Cell Tissue Res 2015; 361: 311-336.
33. Dodge JE, Ramsahoye BH, Wo ZG, Okano M, Li E. De novo methylation of MMLV provirus in embryonic stem cells: CpG versus non-CpG methylation. Gene 2002; 289: 41-48.
34. Haines TR, Rodenhiser DI, Ainsworth PJ. Allele-specific non-CpG methylation of the Nf1 gene during early mouse
development. Developmental Biology 2001; 240: 585-598. 35. Miller C, Sweatt J. Covalent modification of DNA regulates memory formation. Neuron 2007; 53: 857-869.
36. Tucker KL. Methylated cytosine and the brain: a new base for neuroscience. Neuron 2001; 30: 649-652.
37. Sun H, Li K, Shen S. A study of the role of Notch1 and JAG1 gene methylation in development of breast cancer. Med Oncol 2016; 33: 35.